HCM - HUTCHMED (CHINA) - Share Chat

HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company primarily focused on the discovery, development, and commercialisation of oncology and immunology drugs. While its extensive R&D and commercial operations are predominantly based in China, it has a global vision, leveraging its proprietary drug discovery platform to deliver novel therapies worldwide. The company boasts a growing portfolio of approved drugs and late-stage clinical candidates. Listed on the London Stock Exchange, Hong Kong Stock Exchange, and NASDAQ (via ADSs), HUTCHMED is recognised for its strategic partnerships with multinational pharmaceutical companies to expand the reach of its pipeline assets.